Methodist Health System
171
31
39
71
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.4%
16 terminated/withdrawn out of 171 trials
81.6%
-4.9% vs industry average
2%
4 trials in Phase 3/4
0%
0 of 71 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (171)
Evaluation of Hepato-Pancreato-Biliary
Role: lead
Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient
Role: lead
A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center
Role: lead
The Impact of Liver Cirrhosis on Outcomes in Trauma Patients
Role: lead
Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery
Role: lead
Early-Onset Colorectal Cancer Patients Too Young for Screening
Role: lead
Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases
Role: lead
Fetal Outcomes Among Pregnant Emergency General Surgery Patients
Role: lead
Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit
Role: lead
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
Role: lead
Time to Lose the Weight? Comparison of Weight-based and Non-weight-based Vasopressors for Septic Shock
Role: lead
Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis
Role: lead
Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.
Role: lead
Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction
Role: lead
Anticoagulation in Emergency General Surgery
Role: lead
Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
Role: lead
Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function
Role: lead
Management of Extremity Injuries Registry
Role: lead
Fecal Microbiota Transplant
Role: lead
Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)
Role: lead